Page 6 - 《中国药房》2022年12期
P. 6
Research progress on the biotransformation of flavonoid glycosides in Epimedii Folium …………………………
……………… ZHANG Yuhang，CHEN Wang，FENG Zili，YUAN Hongchao，GAO Xiaolin，WANG Cuiping（1525）
Progress in preclinical study of combination of PARP inhibitors against tumor ……………………………………
………………………………………………………… ZHANG Chengyong，LI Yue，YANG Ying，ZHU Riran（1530）
CHINA PHARMACY （Semimonthly）
Founded in January 1990
Vol.33，No.12，Jun. 2022
Total No.726 Published on Jun. 30，2022 Phone
+86-23-63830521；+86-23-63830907；+86-23-68586727；
Responsible Institution +86-23-68586827
National Health Commission，P.R. China E-mail
Sponsored by info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Edited by Online Submission
China Pharmacy Editorial and Publishing Center http：//2018.china-pharmacy.com
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Editor-in-Chief Overseas：China International Book Trading Corporation
HU Xin （Code No.4703SM）
Vice Editor-in-Chief Subscription Rates
LENG Huaiming
Chief Editor CNY 15 per issue；CNY 360 per annum
ZHANG Jian CSSN ISSN 1001-0408
Published by CN 50-1055/R
China Pharmacy Editorial Department CODEN
Postal Address ZYHAA4
129 Daping Main Street，Yuzhong District，Chongqing Perennial Legal Counsel
400042，China Chongqing Huali Wantao Law Firm
